An astonishing factoid from the Lechleiter interview: no company has more than a 2% share of the Chinese pharma market. Obviously, there will be a lot of consolidation in the coming years. Thanks for posting the video.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”